Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling

Fig. 2

Synthesis and characterization of NPs. a The 1H NMR spectra of DSPE-TK-PEG2000 and DSPE-PEG2000. b The appearance of DP@DMF NPs, DTP@DMF NPs, and DTP NPs solution. c Representative TEM images of DTP@DMF NPs (scale bar: 500 nm). d Size distribution of DP@DMF NPs (green), DTP@DMF NPs (red), and DTP NPs (blue). e The average size and f zeta potential of NPs (n = 3). g The change of size and zeta potential of DTP@DMF NPs within 7 days (n = 3). h Changes in the appearances of DTP@DMF NPs and DP@DMF NPs in the presence of 100 μM H2O2. i The cumulative drug release curve of DTP@DMF NPs in the presence of 1 μM, 10 μM, and 100 μM H2O2. Data are expressed as the mean ± SD (n = 3). j Size distribution of DTP@DMF NPs after incubating with 100 μM H2O2 for 9 h

Back to article page